Industry
Medical - Healthcare Information Services
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
May 02, 2024 | 12:17 pm
Portfolio Pulse from Benzinga Insights
May 01, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 8:09 pm
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 8:06 pm
Portfolio Pulse from Benzinga Insights
March 04, 2024 | 5:35 pm
Portfolio Pulse from Benzinga Newsdesk
March 01, 2024 | 5:23 pm
Portfolio Pulse from Benzinga Newsdesk
March 01, 2024 | 2:36 pm
Portfolio Pulse from Benzinga Newsdesk
February 29, 2024 | 8:47 pm
Portfolio Pulse from Avi Kapoor
February 29, 2024 | 7:00 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.